Merck

Merck MKGAF Stock

$169.42   -0.135571%
Add to favorites
Market Cap
$73.66B
LOW - HIGH [24H]
$167.12 - $167.12
VOLUME [24H]
$70.00
P/E Ratio
32.96
Earnings per share
$5.14
ISIN
DE0006599905
Price   Prediction

Merck Price Chart

Sorry, that's all we've gotfor now...

Merck (MKGAF) stock price today is 169.42 USD on OTC Markets OTCPK (-0.14% on the day). Updated .

Merck MKGAF Financial and Trading Overview

Merck stock price 169.42 USD
Previous Close 169.65 USD
Open 167.12 USD
Bid 159.7 USD x 20000
Ask 170.5 USD x 65500
Day's Range 167.12 - 167.12 USD
52 Week Range 116.68 - 175.56 USD
Volume 70 USD
Avg. Volume 609 USD
Market Cap 73.66B USD
Beta (5Y Monthly) 0.814
PE Ratio (TTM) 32.96109
EPS (TTM) 5.14 USD
Forward Dividend & Yield 2.58 (1.52%)
Ex-Dividend Date April 27, 2026
1y Target Est N/A

MKGAF Valuation Measures

Enterprise Value 81.14B USD
Trailing P/E 32.96109
Forward P/E N/A
PEG Ratio (5 yr expected) 2.48
Price/Sales (ttm) 3.4349968
Price/Book (mrq) 2.0823128
Enterprise Value/Revenue 3.784
Enterprise Value/EBITDA 13.399

Trading Information

Merck Stock Price History

Beta (5Y Monthly) 0.814
52-Week Change 26.06%
S&P500 52-Week Change 12.07%
52 Week High 175.56 USD
52 Week Low 116.68 USD
50-Day Moving Average 160.54 USD
200-Day Moving Average 151.88 USD

MKGAF Share Statistics

Avg. Volume (3 month) 609 USD
Avg. Daily Volume (10-Days) 320 USD
Shares Outstanding 129.24M
Float 128.58M
Short Ratio N/A
% Held by Insiders 0%
% Held by Institutions 60.82%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield 133.00%
Payout Ratio 0.4977
Last Split Factor 2:1

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 8.94%
Operating Margin (ttm) 17.03%
Gross Margin 59.00%
EBITDA Margin 28.24%

Management Effectiveness

Return on Assets (ttm) 4.36%
Return on Equity (ttm) 6.40%

Income Statement

Revenue (ttm) 21.44B USD
Revenue Per Share (ttm) 49.36 USD
Quarterly Revenue Growth (yoy) 5.80%
Gross Profit (ttm) 12.65B USD
EBITDA 6.06B USD
Net Income Avi to Common (ttm) 1.92B USD
Diluted EPS (ttm) 5.14
Quarterly Earnings Growth (yoy) -50.10%

Balance Sheet

Total Cash (mrq) 4.27B USD
Total Cash Per Share (mrq) 9.87 USD
Total Debt (mrq) 11.99B USD
Total Debt/Equity (mrq) 38.12 USD
Current Ratio (mrq) 1.69
Book Value Per Share (mrq) 81.36145

Cash Flow Statement

Operating Cash Flow (ttm) 4.37B USD
Levered Free Cash Flow (ttm) 2.23B USD

Profile of Merck

Country United States
State N/A
City Darmstadt
Address Frankfurter Strasse 250
ZIP 64293
Phone 49 6151 72 0
Website https://www.merckgroup.com
Industry Drug Manufacturers - Specialty & Generic
Sector(s) Healthcare
Full Time Employees 61949

Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific. The Life Science segment offers products, solutions, and services to academic, research and diagnostic labs, biotech, and pharmaceutical companies, as well as the industrial sector; reagents, consumables, devices, instruments, software, and services for research, production, and testing to lab water instruments, microbiology and biomonitoring products, test assays, analytical reagents, and flow cytometry kits and instruments. This segment also provides traditional and novel therapies, such as ration devices, chromatography resins, single-use systems, process chemicals, and excipients for bioprocessing; contract development, manufacturing and testing services, which supports customers from preclinical phases to commercialization. The Healthcare segment discovers, develops, manufactures, and markets prescription drugs and biopharmaceuticals to the therapeutic areas of oncology, rare diseases, neurology and immunology, fertility, cardiovascular, and metabolic and endocrinological disorders. The Electronics segment offers advanced dielectric and metallic materials; photoresist, anti-reflective coating, and material lithography products; clean and selective etch chemistries; materials for chemical-mechanical planarization; high-purity gases for semiconductor manufacturing; and develops and installs delivery equipment for handling of specialty chemicals and gases for semiconductor manufacturing; develops modulating, creating, engineering, and guiding light; and material solutions in liquid crystals, OLED materials, and photoresists. It has in-licensing agreement with Abbisko Therapeutics Co. Ltd., China on drug candidates for the treatment of tenosynovial giant cell tumor; and strategic partnership with Versant Ventures to advance treatments for rare genetic cardiomyopathies. The company was founded in 1668 and is headquartered in Darmstadt, Germany. Merck KGaA operates as a subsidiary of E. Merck KG.

Q&A For Merck Stock

What is a current MKGAF stock price?

Merck MKGAF stock price today per share is 169.42 USD.

How to purchase Merck stock?

You can buy MKGAF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Merck?

The stock symbol or ticker of Merck is MKGAF.

Which industry does the Merck company belong to?

The Merck industry is Drug Manufacturers - Specialty & Generic.

How many shares does Merck have in circulation?

The max supply of Merck shares is 434.78M.

What is Merck Price to Earnings Ratio (PE Ratio)?

Merck PE Ratio is 32.96109000 now.

What was Merck earnings per share over the trailing 12 months (TTM)?

Merck EPS is 5.14 USD over the trailing 12 months.

Which sector does the Merck company belong to?

The Merck sector is Healthcare.

$2.17T
Total marketcap
$71.25B
Total volume
BTC 58.09%   •   ETH 9.89%
Dominance
Select currency